Luyan Pharma Co.,Ltd.

SZSE:002788.SZ

8.78 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 5,107.4995,158.15,135.6815,070.3714,750.9145,182.7464,841.5035,138.7354,982.874,703.6284,637.2684,543.0754,528.1424,308.9514,165.234,128.2554,188.193,853.9083,360.9253,881.1033,954.7133,745.5833,427.4783,095.7573,090.7682,714.3962,599.972,349.9572,335.6482,030.9661,621.6621,716.8041,857.91,804.6691,603.5121,729.1421,737.1921,671.3461,488.04
Cost of Revenue 4,746.5464,809.1594,757.5254,649.1574,405.4154,802.7664,479.1334,708.3324,618.7784,322.5984,297.6374,171.784,185.7983,967.7443,848.8913,798.1653,864.8183,534.2843,099.8323,564.453,650.9933,443.9833,180.0592,845.882,857.12,493.1082,404.92,151.9842,164.0331,872.7681,499.6441,576.5961,730.7041,659.0591,486.321,579.2551,609.7861,540.3031,368.204
Gross Profit 360.953348.941378.156421.214345.499379.98362.371430.404364.091381.03339.631371.295342.344341.207316.339330.091323.373319.624261.092316.653303.72301.599247.419249.877233.668221.289195.07197.973171.615158.198122.018140.208127.196145.61117.192149.887127.406131.043119.836
Gross Profit Ratio 0.0710.0680.0740.0830.0730.0730.0750.0840.0730.0810.0730.0820.0760.0790.0760.080.0770.0830.0780.0820.0770.0810.0720.0810.0760.0820.0750.0840.0730.0780.0750.0820.0680.0810.0730.0870.0730.0780.081
Reseach & Development Expenses 0.8981.521.2182.6990.8971.1690.7691.2891.4570.7970.6030.6830.6221.0260.6421.1180.9810.8940.8671.9031.2781.1880.8181.0380.5061.9020.2950.1120.0690.4470000.02600000
General & Administrative Expenses 212.419-55.75778.011-176.069203.169-54.6975.263-173.477201.34-50.3269.785-186.79210.754-57.81476.972-162.39865.964-50.43165.03-192.52875.498-60.7682.274-147.33870.254-38.18458.39-91.33342.494-22.13838.182-82.65837.764-21.36533.395-77.19633.59830.27935.412
Selling & Marketing Expenses 305.043109.663114.821116.362106.968112.889105.494122.992106.606103.84599.33102.71495.62290.86190.13895.70590.2881.98276.295131.15576.62758.59156.22962.08356.86251.55146.68453.23942.46637.13335.38141.59532.77333.18133.75438.74735.86630.40231.121
SG&A 200.341156.638192.832-59.708310.13758.199180.757-50.485307.94653.526169.115-84.075306.37633.047167.11-66.693156.24431.55141.325-61.373152.125-2.169138.504-85.255127.11613.368105.073-38.09484.9614.99673.563-41.06470.53711.81667.149-38.44969.46460.68166.533
Other Expenses -308.5610.9940.0190.571-0.2220.5586.965260.053-117.755135.3238.079.6380.1360.194-0.6330.553-0.246-1.556-1.361-1.313-0.564-0.175-0.0030.953-0.852-0.971-0.3035.158-2.942-1.1820.8132.5160.5990.3070.0121.6150.3221.5010.068
Operating Expenses 209.798157.164203.492213.916188.418197.599188.492210.857191.648189.646177.788200.167185.705172.29174.781181.771163.704155.365145.861185.662163.57142.773144.446147.189132.78116.243109.306122.00988.75780.55876.75285.30572.50472.47969.57379.15772.28763.28268.634
Operating Income 148.222191.777105.521146.1189.965131.22101.262134.684107.137129.06995.055104.207100.558116.67784.43881.346111.622112.56569.19779.16396.296108.36862.30467.49681.90361.54449.99556.24551.99458.87431.53444.48632.9746.85229.71249.49830.35844.11828.253
Operating Income Ratio 0.0290.0370.0210.0290.0190.0250.0210.0260.0220.0270.020.0230.0220.0270.020.020.0270.0290.0210.020.0240.0290.0180.0220.0260.0230.0190.0240.0220.0290.0190.0260.0180.0260.0190.0290.0170.0260.019
Total Other Income Expenses Net -58.806-49.7130.0190.571-0.2220.558-0.041-1.4590.0820.7570.6869.638-55.945-52.046-57.753-66.421-48.292-53.25-47.395-53.141-44.418-50.634-40.672-34.238-19.837-44.474-36.072-14.541-33.809-19.965-12.919-7.913-21.129-25.976-17.902-19.619-24.457-22.143-22.885
Income Before Tax 89.416142.064105.541146.68189.742131.778101.221133.224107.219129.82695.741113.845100.694116.87183.80581.898111.377111.00967.83777.8595.732108.19362.30168.44981.05160.57349.69261.42349.04957.67532.34846.99133.56347.15529.71651.11130.66345.61828.317
Income Before Tax Ratio 0.0180.0280.0210.0290.0190.0250.0210.0260.0220.0280.0210.0250.0220.0270.020.020.0270.0290.020.020.0240.0290.0180.0220.0260.0220.0190.0260.0210.0280.020.0270.0180.0260.0190.030.0180.0270.019
Income Tax Expense 21.51432.37322.01641.24620.77920.28322.6234.20824.68531.73524.40734.64624.94328.39922.61626.03629.26530.43418.57616.94421.16530.93117.52722.13128.71210.66513.67620.68512.73413.0579.01210.0229.10913.9697.55413.5917.66212.0887.161
Net Income 66.973106.59783.776101.55472.962109.15279.86294.29682.09597.05871.70777.33475.39688.4464.57854.97782.5278.81251.21859.64674.96476.8744.40944.19154.54849.20632.37935.0332.09340.24923.20736.88124.18832.7621.69436.91222.59233.04220.934
Net Income Ratio 0.0130.0210.0160.020.0150.0210.0160.0180.0160.0210.0150.0170.0170.0210.0160.0130.020.020.0150.0150.0190.0210.0130.0140.0180.0180.0120.0150.0140.020.0140.0210.0130.0180.0140.0210.0130.020.014
EPS 0.170.270.220.260.190.280.210.240.210.250.180.20.20.230.170.170.250.230.150.170.230.220.130.120.160.140.0930.10.140.110.0660.110.0690.110.0730.140.0880.130.08
EPS Diluted 0.170.270.220.260.190.280.210.240.210.240.180.20.20.230.170.170.250.230.150.170.230.220.130.120.160.140.0930.10.140.110.0660.110.0690.110.0730.140.0880.130.08
EBITDA 140.656227.714171.597222.405141.669189.447165.319232.126158.171194.594155.543186.188153.242168.543137.115146.844156.682161.847114.936138.36138.782158.312101.114102.59599.4596.0591.90166.77388.35374.44547.77437.83158.33969.41549.45764.75561.73467.85353.224
EBITDA Ratio 0.0280.0440.0330.0440.030.0370.0340.0450.0320.0410.0340.0410.0340.0390.0330.0360.0370.0420.0340.0360.0350.0420.030.0330.0320.0350.0350.0280.0380.0370.0290.0220.0310.0380.0310.0370.0360.0410.036